JP2003505156A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003505156A5 JP2003505156A5 JP2001511954A JP2001511954A JP2003505156A5 JP 2003505156 A5 JP2003505156 A5 JP 2003505156A5 JP 2001511954 A JP2001511954 A JP 2001511954A JP 2001511954 A JP2001511954 A JP 2001511954A JP 2003505156 A5 JP2003505156 A5 JP 2003505156A5
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- suspension
- composition
- hydrolyzed starch
- wounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- 102000008186 Collagen Human genes 0.000 description 14
- 108010035532 Collagen Proteins 0.000 description 14
- 229920001436 collagen Polymers 0.000 description 14
- 239000000725 suspension Substances 0.000 description 13
- 229920002472 Starch Polymers 0.000 description 12
- 239000008107 starch Substances 0.000 description 12
- 235000019698 starch Nutrition 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 102000012422 Collagen Type I Human genes 0.000 description 10
- 108010022452 Collagen Type I Proteins 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 229940096422 collagen type i Drugs 0.000 description 10
- 229920002245 Dextrose equivalent Polymers 0.000 description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 229940087168 alpha tocopherol Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229960000984 tocofersolan Drugs 0.000 description 4
- 235000004835 α-tocopherol Nutrition 0.000 description 4
- 239000002076 α-tocopherol Substances 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000035605 chemotaxis Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 235000015438 Cola nitida Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010063562 Radiation skin injury Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 206010044625 Trichorrhexis Diseases 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- -1 ascorbic acid vitamin Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007654 ischemic lesion Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/358,777 | 1999-07-22 | ||
| US09/358,777 US6046160A (en) | 1999-07-22 | 1999-07-22 | Composition and method for enhancing wound healing |
| PCT/US2000/008813 WO2001007071A1 (en) | 1999-07-22 | 2000-03-31 | Composition and method for enhancing wound healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003505156A JP2003505156A (ja) | 2003-02-12 |
| JP2003505156A5 true JP2003505156A5 (enExample) | 2007-05-24 |
Family
ID=23411005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001511954A Pending JP2003505156A (ja) | 1999-07-22 | 2000-03-31 | 傷の治療を向上させる方法及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6046160A (enExample) |
| EP (1) | EP1206271B1 (enExample) |
| JP (1) | JP2003505156A (enExample) |
| AT (1) | ATE275965T1 (enExample) |
| AU (1) | AU778792B2 (enExample) |
| BR (1) | BR0013038A (enExample) |
| CA (1) | CA2378760A1 (enExample) |
| DE (1) | DE60013857D1 (enExample) |
| WO (1) | WO2001007071A1 (enExample) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7112320B1 (en) | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
| US6528483B2 (en) | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
| ATE220564T1 (de) * | 1997-08-14 | 2002-08-15 | Sulzer Innotec Ag | Zusammensetzung und vorrichtung zur reparatur von knorpelgewebe in vivo bestehend aus nanokapseln mit osteoinduktiven und/oder chondroinduktiven faktoren |
| US6046160A (en) * | 1999-07-22 | 2000-04-04 | Deroyal Industries, Inc. | Composition and method for enhancing wound healing |
| US6992062B2 (en) * | 2000-05-31 | 2006-01-31 | Encelle, Inc. | Method of stimulation hair growth |
| US6432425B1 (en) | 2000-09-08 | 2002-08-13 | Al Siamon | Method for treatment with an antibacterial and antiseptic mixture |
| WO2002083046A1 (en) | 2001-04-16 | 2002-10-24 | Pamela Howard | Wound dressing system |
| US20030068297A1 (en) * | 2001-08-18 | 2003-04-10 | Deepak Jain | Composition and methods for skin rejuvenation and repair |
| RU2232551C2 (ru) * | 2002-01-08 | 2004-07-20 | Ковалев Алексей Вячеславович | Способ аутотрансплантации клеток кожи |
| EP1342474A1 (en) * | 2002-03-08 | 2003-09-10 | Universiteit Leiden | The use of proline, poly-proline peptides and proline-rich proteins to quench reactive oxygen species |
| US20030206893A1 (en) * | 2002-05-06 | 2003-11-06 | Sohail Malik | Cell proliferating agents |
| US20040001878A1 (en) * | 2002-06-26 | 2004-01-01 | Deroyal Industries, Inc. | Infused wound care dressings |
| US7290197B2 (en) * | 2003-06-03 | 2007-10-30 | Quantum Corporation | Correcting data using redundancy blocks |
| US8673366B2 (en) * | 2004-06-14 | 2014-03-18 | Kareem I. Batarseh | Chemotherapeutic and prophylactic pharmaceutical compositions |
| US7754194B2 (en) * | 2005-04-06 | 2010-07-13 | L'oréal | Hair relaxer compositions utilizing bioactive glass |
| US20060282028A1 (en) * | 2005-06-10 | 2006-12-14 | Howard Pamela A | Wound Management System |
| US20060293228A1 (en) * | 2005-06-24 | 2006-12-28 | Bhatnagar Rajendra S | Therapeutic compositions and methods using transforming growth factor-beta mimics |
| US20070003541A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for therapeutics |
| US20070128685A1 (en) * | 2005-07-01 | 2007-06-07 | Rodolfo Faudoa | Methods and compositions for cell culture |
| US20070004036A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for keratinocyte culture |
| CA2623940C (en) * | 2005-09-27 | 2017-01-10 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
| JP2009510087A (ja) * | 2005-09-30 | 2009-03-12 | オーエムピー インコーポレーテッド | 安定アスコルビン酸組成物 |
| US20070269534A1 (en) * | 2006-02-02 | 2007-11-22 | Ramirez Jose E | Methods of treating skin to enhance therapeutic treatment thereof |
| US20070178058A1 (en) * | 2006-02-02 | 2007-08-02 | Ramirez Jose E | Methods of using stable ascorbic acid compositions |
| US7834153B2 (en) * | 2006-06-05 | 2010-11-16 | University Of South Florida | Combination of insulin and ascorbate to enhance wound healing |
| EP2345433B1 (en) * | 2008-10-06 | 2017-03-01 | 3-D Matrix, Ltd. | Tissue plug |
| US8034363B2 (en) * | 2008-12-11 | 2011-10-11 | Advanced Technologies And Regenerative Medicine, Llc. | Sustained release systems of ascorbic acid phosphate |
| FR2945043B1 (fr) * | 2009-04-30 | 2019-07-26 | Roquette Freres | Procede de purification de polymeres de glucose destines aux solutions de dialyse peritoneale |
| US20150093449A1 (en) * | 2009-06-24 | 2015-04-02 | Donald H. Brancato | Method of Using Silicon Substituted Phosphates to Improve Healing of Bone and Soft Tissue |
| US8591459B2 (en) * | 2009-12-21 | 2013-11-26 | Ethicon Endo-Surgery, Inc. | Use of biomarkers and therapeutic agents with surgical devices |
| US8951598B2 (en) * | 2010-05-07 | 2015-02-10 | Empire Technology Development Llc | Nanoscale collagen particles and membranes |
| CN102008740B (zh) * | 2010-12-01 | 2014-11-12 | 吴涛 | 一种可吸收生长因子复合敷料 |
| US9526770B2 (en) | 2011-04-28 | 2016-12-27 | Tissuetech, Inc. | Methods of modulating bone remodeling |
| US20130085461A1 (en) * | 2011-10-04 | 2013-04-04 | Dermal Therapy (Barbados) Inc. | Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof |
| US20140330192A1 (en) * | 2012-02-13 | 2014-11-06 | The Ex Plant Company | Dressing for application to a wound or burn |
| JP6389170B2 (ja) | 2012-07-06 | 2018-09-12 | スリーディー マトリックス， エルティーディー３−Ｄ Ｍａｔｒｉｘ， Ｌｔｄ． | ペプチド溶液のためのフィル−フィニッシュ過程 |
| EP2916830A2 (en) * | 2012-11-08 | 2015-09-16 | Summa Health System | Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing |
| US9393278B2 (en) | 2013-06-26 | 2016-07-19 | Han Sheng Biotech Co., Ltd. | Method for wound healing |
| CA2939696C (en) | 2014-03-10 | 2023-01-10 | 3-D Matrix, Ltd. | Self-assembling peptide compositions |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| JP6684719B2 (ja) | 2014-03-10 | 2020-04-22 | 株式会社スリー・ディー・マトリックス | ペプチド組成物の滅菌および濾過 |
| TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
| WO2016138025A2 (en) | 2015-02-23 | 2016-09-01 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
| JP2018516869A (ja) | 2015-05-20 | 2018-06-28 | ティッシュテック，インク． | 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法 |
| WO2017120092A1 (en) | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
| TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
| CN110997020A (zh) * | 2017-02-08 | 2020-04-10 | Hkl医疗有限责任公司 | 位点内施用和剂量方法以及其中使用的药物 |
| EP3723726A1 (en) | 2017-12-15 | 2020-10-21 | 3-D Matrix, Ltd. | Surfactant peptide nanostructures and uses in drug delivery |
| US20220072078A1 (en) | 2018-12-26 | 2022-03-10 | Katherine Echo Kim | Compositions and methods for treating burns, wounds, and skin disorders |
| CN114144205A (zh) | 2019-07-24 | 2022-03-04 | 赫斯特细胞有限公司 | 用于伤口愈合的新抗氧化剂组合物 |
| US11000540B1 (en) | 2019-11-22 | 2021-05-11 | Al Siamon | Treatment for reducing adverse events including chemotherapy discomfort and other conditions |
| US11253595B2 (en) | 2019-11-22 | 2022-02-22 | Al Siamon | Treatment for reducing adverse events including chemotherapy discomfort and other conditions |
| GB201919385D0 (en) | 2019-12-27 | 2020-02-05 | Phoenix Eagle Company Pty Ltd | Compositions and methods of manufacture |
| CN114591419B (zh) * | 2022-03-07 | 2022-09-23 | 山东大学 | 一种热水解蛋白及其制备方法和应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1165243A (en) * | 1980-02-19 | 1984-04-10 | Anthony N. Silvetti | Method and composition for treatment of wounds |
| US4570629A (en) * | 1982-03-17 | 1986-02-18 | University Of Illinois Foundation | Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same |
| AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
| US4837024A (en) * | 1984-02-24 | 1989-06-06 | The Regents Of The University Of California | Compositions, articles and mehtod for improving wound healing |
| US4837285A (en) * | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
| DE3686022D1 (de) * | 1985-10-22 | 1992-08-20 | Silvetti Sen | Monosaccharide enthaltende zusammensetzung zum heilen von wunden. |
| JPS62161729A (ja) * | 1985-10-22 | 1987-07-17 | アンソニ− エヌ シルベツテイ シニア | 単糖を含有する創傷治療剤 |
| CA1294546C (en) * | 1986-04-23 | 1992-01-21 | John S. Sundsmo | Wound healing composition containing collagen |
| US5196196A (en) * | 1986-06-03 | 1993-03-23 | Incyte Pharmaceuticals, Inc. | Use of protease nexin-I in wound dressings |
| US5133965A (en) * | 1988-06-08 | 1992-07-28 | Fountain Pharmaceuticals, Inc. | Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution |
| GB9027106D0 (en) * | 1990-12-13 | 1991-02-06 | Cerester Holding B V | Starch composition |
| US5177065A (en) * | 1990-12-26 | 1993-01-05 | Silvetti Sr Anthony N | Monosaccharide containing wound healing preparation |
| US5658957A (en) * | 1991-03-01 | 1997-08-19 | Warner Lambert Company | Immunostimulating wound healing compositions and method for preparing and using same |
| US5633285A (en) * | 1991-03-01 | 1997-05-27 | Warner-Lambert Company | Cytoprotective wound healing compositions and methods for preparing and using same |
| US5874479A (en) * | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
| US5658956A (en) * | 1991-03-01 | 1997-08-19 | Warner-Lambert Company | Bioadhesive-wound healing compositions and methods for preparing and using same |
| EP0614359A1 (en) * | 1991-11-26 | 1994-09-14 | Warner-Lambert Company | Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| AU667549B2 (en) * | 1992-06-08 | 1996-03-28 | North West University | Nitrous oxide containing dermatological composition |
| GB2276819B (en) * | 1993-03-23 | 1996-12-11 | Johnson & Johnson Medical | Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol |
| GB2291348B (en) * | 1994-07-18 | 1999-01-20 | Johnson & Johnson Medical | Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol |
| GB9415739D0 (en) * | 1994-07-30 | 1994-09-21 | Scimat Ltd | Gel wound dressing |
| US5578576A (en) * | 1994-09-02 | 1996-11-26 | Dalhousie University | Method and composition for treating intestinal wounds or ulcers |
| US5676967A (en) * | 1995-04-18 | 1997-10-14 | Brennen Medical, Inc. | Mesh matrix wound dressing |
| AU7519396A (en) * | 1995-10-26 | 1997-05-15 | Lange Medical Products, Inc. | Method of treating wounds with a gel composition |
| US5800372A (en) * | 1996-01-09 | 1998-09-01 | Aerojet-General Corporation | Field dressing for control of exsanguination |
| US5834008A (en) * | 1996-09-19 | 1998-11-10 | U.S. Biomaterials Corp. | Composition and method for acceleration of wound and burn healing |
| CA2308146A1 (en) * | 1997-07-28 | 1999-02-04 | Thomas B. Neff | Collagen type i and type iii adhesive compositions |
| US6046160A (en) * | 1999-07-22 | 2000-04-04 | Deroyal Industries, Inc. | Composition and method for enhancing wound healing |
-
1999
- 1999-07-22 US US09/358,777 patent/US6046160A/en not_active Expired - Lifetime
- 1999-12-10 US US09/459,753 patent/US6187743B1/en not_active Expired - Lifetime
-
2000
- 2000-03-31 AU AU41915/00A patent/AU778792B2/en not_active Ceased
- 2000-03-31 DE DE60013857T patent/DE60013857D1/de not_active Expired - Lifetime
- 2000-03-31 CA CA002378760A patent/CA2378760A1/en not_active Abandoned
- 2000-03-31 AT AT00921622T patent/ATE275965T1/de not_active IP Right Cessation
- 2000-03-31 WO PCT/US2000/008813 patent/WO2001007071A1/en not_active Ceased
- 2000-03-31 EP EP00921622A patent/EP1206271B1/en not_active Expired - Lifetime
- 2000-03-31 JP JP2001511954A patent/JP2003505156A/ja active Pending
- 2000-03-31 BR BR0013038-9A patent/BR0013038A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003505156A5 (enExample) | ||
| Rao et al. | Use of dry human and bovine amnion as a biological dressing | |
| JP4615223B2 (ja) | コラーゲンバイオ繊維、ならびにその調製方法および使用 | |
| US4778679A (en) | Method and composition for treatment of wounds | |
| JPS60122568A (ja) | 親水性バイオポリマーコポリエレクトロライト | |
| Vachhrajani et al. | Science of wound healing and dressing materials | |
| EA010316B1 (ru) | Перевязочный материал на основе целлюлозы микробного происхождения, его применение и содержащий его набор | |
| JPH0636815B2 (ja) | 人工皮膜代用品としてのセルロース皮膜の製造方法 | |
| CN116390691A (zh) | 自组装的两亲性肽水凝胶 | |
| JP2012516891A (ja) | 生物組織のための二酸化塩素治療 | |
| DK160231B (da) | Anvendelse af protein til fremstilling af et middel til fjernelse af mikroorganismer fra vaev | |
| KR20010042539A (ko) | 액체매체 속의 천연 콜라겐의 멸균 방법, 획득된 멸균천연 콜라겐, 그 것을 함유하는 조성물 및 용도 | |
| JP3550685B2 (ja) | 創傷治療剤 | |
| JPS5888316A (ja) | 傷治癒用組成物、その製法及び利用 | |
| TWI277393B (en) | Acidic solution of sparingly-soluble group IIA complexes | |
| AU2021325682A1 (en) | Antimicrobial matrix formed from peptide hydrogels | |
| CA1165243A (en) | Method and composition for treatment of wounds | |
| RU2281088C2 (ru) | Пористый губчатый целлюлозный материал для лечения ран | |
| US20130052256A1 (en) | Nail discoloration and fungus treatment | |
| JP2005501016A (ja) | 抗菌性材料 | |
| ES2916806T3 (es) | Composición antiinflamatoria para ayudar y promover la cicatrización de lesiones ulcerativas crónicas | |
| CN109200326A (zh) | 用于伤口愈合的敷料及创口贴 | |
| WO2022035784A1 (en) | Antifungal matrix formed from peptide hydrogels | |
| RU2229872C1 (ru) | Средство местного действия, оказывающее стимулирующее влияние на процессы восстановления клеток | |
| CN107260591B (zh) | 抗菌抗病毒护手霜及其制备方法 |